CN219578881U

CN219578881U - Glucose monitoring probe and glucose monitor

Info

Publication number: CN219578881U
Application number: CN202320673455.4U
Authority: CN
Inventors: 罗鸿耀; 李先海
Original assignee: Shunyuankang Shenzhen Technology Co ltd
Current assignee: Shunyuankang Shenzhen Technology Co ltd
Priority date: 2023-03-24
Filing date: 2023-03-24
Publication date: 2023-08-25
Anticipated expiration: 2033-03-24

Abstract

The utility model discloses a glucose monitoring probe and a glucose monitor, which comprises a monitoring probe, wherein the monitoring probe is used for being implanted into subcutaneous tissue of a human body to generate voltage through electrochemical reaction with glucose, the monitoring probe is provided with an enzyme electrode A and an enzyme electrode B, the enzyme electrode A and the enzyme electrode B are respectively used as positive and negative electrodes for generating voltage when the monitoring probe and the glucose are subjected to electrochemical reaction, and the potential difference between the enzyme electrode A and the enzyme electrode B, namely the voltage, is measured in real time to realize real-time monitoring of the glucose content in human blood. According to the utility model, the reference electrode is omitted by arranging the A enzyme electrode and the B enzyme electrode, the potential difference between the A enzyme electrode potential and the B enzyme electrode potential is measured in real time to monitor the glucose content in human blood in real time, the whole monitoring probe has higher measurement sensitivity, the measurement mode is simpler and more convenient, and the service life is longer.

Description

Glucose monitoring probe and glucose monitor

Technical Field

The utility model relates to the field of glucose monitoring, in particular to a glucose monitoring probe and a glucose monitor.

Background

The monitoring of the physical signs of the human body is an important means for preventing and treating diseases of the human body, the monitoring of the physical signs comprises measuring a series of physiological parameters which can display the health condition of the individual, such as blood sugar monitoring, and the monitoring is an important means for diagnosing and treating diabetes, and particularly, along with the gradual increase of diabetics in recent years, the monitoring of the blood sugar change of the patients in real time is very important.

Currently, implantable glucose monitoring probes are often used to implant into human skin to monitor the concentration of glucose in the blood in real time, thereby reflecting the blood glucose level of the patient.

In the prior art, the response speed of a glucose monitoring probe is low, so that the sensitivity of glucose monitoring in real time is low;

the service life of the existing glucose monitoring probe is generally about 14 days, and the requirement of a diabetic patient on long-time glucose real-time monitoring cannot be met;

in addition, some glucose monitoring probes in the prior art, such as patent No. 201811640898.3, are named as working electrodes of a glucose monitoring probe, and the electrodes used by the glucose monitoring probe comprise a working electrode, a reference electrode and a counter electrode, and three electrodes are used, and the blood glucose is read by using the reference electrode.

Disclosure of Invention

The utility model aims to solve the technical problems that the glucose monitoring probe and the glucose monitor are characterized in that by arranging an A enzyme electrode and a B enzyme electrode, a reference electrode is omitted, and the potential difference between the potential of the A enzyme electrode and the potential of the B enzyme electrode is used for monitoring the glucose content in human blood in real time, so that the whole monitoring probe has longer service life, higher sensitivity and simpler and more convenient measuring mode, and the problems of low measuring sensitivity, short service life and troublesome measuring of the monitoring probe in the prior art are effectively solved.

The utility model is realized by the following technical scheme: a glucose monitoring probe comprising:

the monitoring probe is used for generating voltage through electrochemical reaction with glucose;

the monitoring probe is provided with an enzyme electrode A and an enzyme electrode B, and the enzyme electrode A and the enzyme electrode B are respectively used as a positive electrode and a negative electrode for generating voltage when the monitoring probe and glucose are subjected to electrochemical reaction.

As a preferable technical scheme, the monitoring probe comprises an FPC flexible electrode and a sensing layer arranged on the FPC flexible electrode.

As a preferable technical scheme, the sensing layer carries glucose dehydrogenase, and the glucose dehydrogenase and glucose react electrochemically to generate voltage.

As a preferable technical scheme, the sensing layer is further provided with a biocompatible film layer, and the biocompatible film layer is used for filtering glucose to control the passing rate of the glucose.

As the preferable technical scheme, the FPC flexible electrode comprises an FPC board, an A enzyme electrode and a B enzyme electrode, wherein the A enzyme electrode and the B enzyme electrode are arranged on the FPC board.

As a preferable technical scheme, the enzyme A electrode and the enzyme B electrode are not coplanar and are respectively positioned on two opposite sides of the FPC board.

As a preferable technical scheme, the enzyme electrode A and the enzyme electrode B are arranged in a staggered manner.

As a preferable technical scheme, an electrode extension sheet is arranged on the FPC board along the extension direction of the FPC board, and the enzyme A electrode and the enzyme B electrode are respectively arranged on the front side and the back side of the farthest end of the electrode extension sheet.

As an optimal technical scheme, a conductive circuit is arranged on the electrode extension sheet, and the enzyme A electrode and the enzyme B electrode are electrically connected with the FPC board through the conductive circuit.

The utility model relates to a glucose monitor, which comprises a glucose monitoring probe.

The beneficial effects of the utility model are as follows: the utility model adopts an electrochemical measurement mode of the glucose dehydrogenase electrode, and the voltage generated by electron migration in the reaction process of glucose and glucose dehydrogenase is measured in real time, so that the real-time monitoring of the glucose content in human blood is realized;

in addition, the utility model changes the chemical reaction generated by the two electrodes to form a loop and generate voltage, and can realize the real-time monitoring of the glucose content in human blood only by measuring the potential difference between the electrode potential of the enzyme A and the electrode potential of the enzyme B in real time, namely the voltage, thereby being simpler and more convenient.

Drawings

In order to more clearly illustrate the embodiments of the utility model or the technical solutions in the prior art, the drawings that are required in the embodiments or the description of the prior art will be briefly described, it being obvious that the drawings in the following description are only some embodiments of the utility model, and that other drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.

FIG. 1 is a schematic diagram of the structure of a glucose monitoring probe;

FIG. 2 is a front view of the FPC flexible electrode of the glucose monitoring probe;

FIG. 3 is a rear view of the FPC flex electrode of the glucose monitoring probe;

FIG. 4 is a schematic view of a glucose monitoring probe in use;

reference numerals illustrate:

1. a biocompatible membrane layer; 2. a sensing layer; 3. flexible electrodes of FPC; 4. an FPC board; 5. an electrode extension sheet; 6. an enzyme electrode; 7. a B enzyme electrode; 100. monitoring a probe; 200. glucose.

Detailed Description

All of the features disclosed in this specification, or all of the steps in a method or process disclosed, may be combined in any combination, except for mutually exclusive features and/or steps.

Any feature disclosed in this specification (including any accompanying claims, abstract and drawings), may be replaced by alternative features serving the same, equivalent or similar purpose, unless expressly stated otherwise. That is, each feature is one example only of a generic series of equivalent or similar features, unless expressly stated otherwise.

As shown in fig. 4, a glucose monitoring probe of the present utility model includes a monitoring probe 100, wherein the monitoring probe 100 is implanted into subcutaneous tissue of a human body, and generates a voltage after electrochemical reaction with glucose 200 in blood of the human body, and the monitoring probe 100 needs to puncture skin tissue of the human body and extend into the skin tissue of the human body so as to be in optimal contact with the glucose 200 in the subcutaneous tissue of the human body;

as shown in fig. 2 and 3, the monitoring probe 100 of the present utility model has an a enzyme electrode 6 and a B enzyme electrode 7, and the a enzyme electrode 6 and the B enzyme electrode 7 are used as the positive and negative electrodes for generating voltage during monitoring of the monitoring probe 100, electrons are transmitted between the a enzyme electrode 6 and the B enzyme electrode 7 and form a loop, and the potential difference between the a enzyme electrode 6 and the B enzyme electrode 7 is measured to monitor the glucose 200 content in human blood in real time.

As shown in fig. 1, the monitoring probe 100 comprises an FPC flexible electrode 3 and a sensing layer 2 arranged on the FPC flexible electrode 3, wherein the sensing layer 2 carries glucose dehydrogenase, the glucose dehydrogenase and glucose 200 in human blood react electrochemically to generate a voltage, the sensing layer 2 is also provided with a biocompatible film layer 1, and the biocompatible film layer 1 is used for filtering the glucose 200 and controlling the passing rate of the glucose 200; due to the arrangement of the biocompatible film layer 1, the service life of the glucose 200 monitoring probe 100 is prolonged, interference of other factors is reduced, and the reaction speed of the glucose 200 monitoring probe 100 to the glucose 200 is improved.

The FPC flexible electrode 3 is adopted, so that the utility model can be clung to the skin, and the influence on the daily life of a user is reduced. In some examples, the shape may be circular, and in some examples, a waterproof housing and waterproof band-aid may be provided, thereby enabling the user to use the device without affecting daily activities such as swimming or bathing.

In this embodiment, the flexible FPC electrode 3 includes the FPC board 4, the enzyme electrode a 6 and the enzyme electrode B7 are all disposed on the FPC board 4, the enzyme electrode a 6 and the enzyme electrode B7 are not coplanar and are located on two opposite sides of the FPC board 4 respectively, and the flexible FPC electrode a and the enzyme electrode B7 are disposed on two opposite sides of the FPC board 4 by being separated from each other, and only have two electrodes, so the flexible FPC is thinner and lighter in structure, the potential difference can be formed by using the structural layout of the front and the back, the potential difference can be generated while the structure is simplified, further the measurement and the reading of the glucose 200 result can be realized, the structural design is more reasonable, the whole monitoring probe 100 is smaller and more compact, the whole cost is reduced, and the detection and the reading are convenient.

Specifically, the enzyme electrode A6 and the enzyme electrode B7 are staggered, electrons are transmitted between the enzyme electrode A6 and the enzyme electrode B7 to form a loop, and the content of glucose 200 in human blood is monitored in real time by measuring the potential difference between the potential of the enzyme electrode A6 and the potential of the enzyme electrode B7.

In order to better layout the enzyme electrode A6 and the enzyme electrode B7, in this embodiment, electrode extension sheets 5 are arranged on the FPC board 4 along the extension of the FPC board 4, the enzyme electrode A6 and the enzyme electrode B7 are respectively arranged on the front and back surfaces of the most distal end of the electrode extension sheets 5, the enzyme electrode A6 and the enzyme electrode B7 are required to be in a front and back layout, and thus, the electrode A6 and the electrode B7 are adopted as positive and negative electrodes, and potential difference is formed between the electrode A6 and the electrode B7 to monitor the glucose 200, so that the mode only needs to arrange the enzyme electrode A6 and the enzyme electrode B7, and the monitoring and the measurement can be completed without arranging a third electrode;

the electrode extension sheet 5 is provided with a conductive circuit, the enzyme A electrode 6 and the enzyme B electrode 7 are connected with the FPC board 4 through the conductive circuits, the length of the electrode extension sheet 5 is selected according to actual needs, and the conductive circuit is arranged inside or outside the electrode extension sheet 5 and is used as bottom transmission of the electrode.

Glucose 200 in blood is polyhydroxy aldehyde, the molecular formula is C6H1206, glucose 200 molecules contain 5 hydroxyl groups and 1 aldehyde group, the aldehyde groups in the molecules can be reduced and oxidized, the hydroxyl groups in the molecules can be subjected to esterification reaction with acid, and the reaction process of glucose 200 in vivo and glucose dehydrogenase is as follows:

NADH+Fe ³⁺ →Fe ²⁺ +NAD ⁺ (2)

(wherein, β -D-Glucose represents Glucose, glucose dehydrogenase represents Glucose dehydrogenase, D-Glucono- δ -lactone represents gluconolactone, NAD represents oxidized coenzyme, and NADH represents reduced coenzyme).

The specific steps of the method for realizing glucose 200 monitoring of the utility model are as follows:

firstly, the monitoring probe 100 is implanted into human skin tissue, so that the A enzyme electrode 6 and the B enzyme electrode 7 on the FPC board 4 are contacted with glucose 200 in the human body; after the whole probe is implanted into human skin tissue, glucose dehydrogenase carried by the sensing layer 2 on the FPC flexible electrode 3 electrochemically reacts with glucose 200 in human blood, so that a voltage is generated; in order to filter glucose 200 to control the rate of glucose 200 passing, a biocompatible membrane layer 1 is disposed on sensing layer 2; when electrochemical reaction occurs, electrons are transmitted between the enzyme A electrode 6 and the enzyme B electrode 7 to form a loop; by using the measuring equipment, the detection value on the equipment is read by measuring the potential difference between the potential of the enzyme electrode A6 and the potential of the enzyme electrode B7, so that the real-time monitoring of the glucose 200 content in human blood is realized.

Specifically, by adopting the electrochemical measurement mode of the glucose dehydrogenase electrode, the real-time monitoring of the content of glucose 200 in human blood is realized by measuring the voltage generated by electron migration in the reaction process of glucose 200 and glucose dehydrogenase in real time, and the electrochemical measurement mode has high catalytic activity and oxygen insensitivity, so that the glucose monitoring probe has higher sensitivity, and the service life of the glucose monitoring probe is prolonged;

in addition, the utility model only needs two electrodes to generate chemical reaction to form a loop and generate voltage, and only needs to measure the potential difference between the potential of the enzyme A electrode 6 and the potential of the enzyme B electrode 7, namely the voltage, so that the real-time monitoring of the glucose 200 content in human blood can be realized, and the utility model is simpler and more convenient.

In this embodiment, the voltage value between the enzyme electrode a 6 and the enzyme electrode B7 can be detected by using an external detection device, and the electrical signal is converted into a digital signal by using an a/D converter and output, so as to achieve the reading of the blood glucose parameter, where the frequency of reading can be interval, for example, the electrical signal is received once every 5 seconds, and the interval time can be set in advance as required.

The foregoing is merely illustrative of specific embodiments of the present utility model, and the scope of the utility model is not limited thereto, but any changes or substitutions that do not undergo the inventive effort should be construed as falling within the scope of the present utility model. Therefore, the protection scope of the present utility model should be subject to the protection scope defined by the claims.

Claims

1. A glucose monitoring probe, comprising:

a monitoring probe (100), the monitoring probe (100) being configured to electrochemically react with glucose (200) to generate a voltage;

the monitoring probe (100) is provided with an A enzyme electrode (6) and a B enzyme electrode (7), and the A enzyme electrode (6) and the B enzyme electrode (7) are respectively used as a positive electrode and a negative electrode for generating voltage when the monitoring probe (100) and glucose (200) are subjected to electrochemical reaction.

2. The glucose monitoring probe of claim 1, wherein: the monitoring probe (100) comprises an FPC flexible electrode (3) and a sensing layer (2) arranged on the FPC flexible electrode (3).

3. The glucose monitoring probe of claim 2, wherein: the sensing layer (2) carries glucose dehydrogenase, and the glucose dehydrogenase and glucose (200) are subjected to electrochemical reaction to generate voltage.

4. The glucose monitoring probe of claim 2, wherein: the sensing layer (2) is also provided with a biocompatible film layer (1), and the biocompatible film layer (1) is used for filtering the glucose (200) so as to control the passing rate of the glucose (200).

5. The glucose monitoring probe of any one of claims 2 to 4, wherein: the FPC flexible electrode (3) comprises an FPC board (4), an A enzyme electrode (6) and a B enzyme electrode (7), wherein the A enzyme electrode (6) and the B enzyme electrode (7) are arranged on the FPC board (4).

6. The glucose monitoring probe of claim 5, wherein: the enzyme A electrode (6) and the enzyme B electrode (7) are not coplanar and are respectively positioned on two opposite sides of the FPC board (4).

7. The glucose monitoring probe of claim 6, wherein: the enzyme A electrode (6) and the enzyme B electrode (7) are arranged in a staggered mode.

8. The glucose monitoring probe of claim 6 or 7, wherein: an electrode extension sheet (5) is arranged on the FPC board (4) along the extension direction of the FPC board (4), and the enzyme A electrode (6) and the enzyme B electrode (7) are respectively arranged on the front side and the back side of the farthest end of the electrode extension sheet (5).

9. The glucose monitoring probe of claim 8, wherein: and the electrode extension sheet (5) is provided with a conductive circuit, and the enzyme A electrode (6) and the enzyme B electrode (7) are electrically connected with the FPC board (4) through the conductive circuit.

10. A glucose monitor, characterized by: a glucose monitoring probe comprising any one of claims 1 to 9.